| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Glucose | 115 | 2023 | 1117 | 3.990 |
Why?
|
| Insulin | 109 | 2021 | 1149 | 3.880 |
Why?
|
| Gluconeogenesis | 28 | 2020 | 93 | 3.510 |
Why?
|
| Lactation | 15 | 2020 | 195 | 3.150 |
Why?
|
| Glucose | 56 | 2021 | 853 | 3.080 |
Why?
|
| Leucine | 59 | 2006 | 259 | 2.530 |
Why?
|
| Hypoglycemia | 29 | 2017 | 190 | 2.420 |
Why?
|
| Glucagon | 52 | 2017 | 146 | 2.410 |
Why?
|
| Diabetes Mellitus, Type 1 | 29 | 2017 | 895 | 2.410 |
Why?
|
| Milk, Human | 11 | 2022 | 321 | 2.110 |
Why?
|
| Insulin Resistance | 23 | 2021 | 690 | 2.050 |
Why?
|
| Galactose | 6 | 2015 | 53 | 1.600 |
Why?
|
| Hypoglycemic Agents | 17 | 2023 | 480 | 1.560 |
Why?
|
| Mammary Glands, Human | 5 | 2015 | 79 | 1.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2024 | 1459 | 1.360 |
Why?
|
| Fasting | 32 | 2018 | 303 | 1.310 |
Why?
|
| Hyperglycemia | 18 | 2018 | 234 | 1.300 |
Why?
|
| Human Growth Hormone | 8 | 2016 | 74 | 1.260 |
Why?
|
| Dietary Carbohydrates | 8 | 2014 | 106 | 1.250 |
Why?
|
| Carbon Isotopes | 19 | 2015 | 227 | 1.150 |
Why?
|
| Proteins | 23 | 2006 | 1006 | 1.100 |
Why?
|
| Lipodystrophy | 3 | 2023 | 37 | 1.040 |
Why?
|
| Growth Hormone | 29 | 2005 | 130 | 1.040 |
Why?
|
| Insulin-Like Growth Factor I | 12 | 2011 | 324 | 0.950 |
Why?
|
| C-Peptide | 18 | 2023 | 107 | 0.880 |
Why?
|
| Glycogenolysis | 3 | 2018 | 10 | 0.860 |
Why?
|
| Lactose | 4 | 2020 | 55 | 0.840 |
Why?
|
| Amyloid | 4 | 2009 | 72 | 0.820 |
Why?
|
| Keto Acids | 29 | 1993 | 50 | 0.820 |
Why?
|
| Hormones | 9 | 2017 | 162 | 0.810 |
Why?
|
| Kinetics | 45 | 2009 | 1088 | 0.800 |
Why?
|
| Leptin | 2 | 2023 | 218 | 0.780 |
Why?
|
| Obesity | 18 | 2022 | 2426 | 0.770 |
Why?
|
| Fructose | 5 | 2009 | 60 | 0.740 |
Why?
|
| Humans | 244 | 2024 | 131163 | 0.720 |
Why?
|
| Models, Biological | 14 | 2015 | 1371 | 0.700 |
Why?
|
| Prednisone | 11 | 2009 | 235 | 0.700 |
Why?
|
| Dietary Fats | 5 | 2013 | 278 | 0.690 |
Why?
|
| Glutamine | 15 | 2015 | 200 | 0.690 |
Why?
|
| Glycolipids | 3 | 2011 | 33 | 0.690 |
Why?
|
| Glycerol | 13 | 2015 | 78 | 0.680 |
Why?
|
| Adult | 110 | 2024 | 31282 | 0.670 |
Why?
|
| Female | 157 | 2024 | 70963 | 0.670 |
Why?
|
| Bariatric Surgery | 2 | 2020 | 154 | 0.660 |
Why?
|
| Adolescent | 71 | 2024 | 20987 | 0.610 |
Why?
|
| Energy Metabolism | 12 | 2012 | 804 | 0.610 |
Why?
|
| Homeostasis | 13 | 2012 | 712 | 0.610 |
Why?
|
| Breast Feeding | 5 | 2020 | 240 | 0.600 |
Why?
|
| Eating | 11 | 2014 | 377 | 0.600 |
Why?
|
| Glycoproteins | 3 | 2011 | 346 | 0.580 |
Why?
|
| Triglycerides | 8 | 2014 | 602 | 0.570 |
Why?
|
| Amino Acids | 31 | 2003 | 566 | 0.570 |
Why?
|
| Fatty Acids, Nonesterified | 25 | 2009 | 112 | 0.560 |
Why?
|
| Oxidation-Reduction | 26 | 2009 | 436 | 0.560 |
Why?
|
| Lipid Metabolism | 5 | 2010 | 387 | 0.550 |
Why?
|
| Islets of Langerhans | 7 | 2013 | 163 | 0.540 |
Why?
|
| Diabetic Ketoacidosis | 5 | 2015 | 170 | 0.540 |
Why?
|
| Insulin Infusion Systems | 7 | 2017 | 67 | 0.540 |
Why?
|
| Carbon Radioisotopes | 24 | 1997 | 61 | 0.540 |
Why?
|
| Ketone Bodies | 27 | 2009 | 41 | 0.530 |
Why?
|
| Glucose Tolerance Test | 13 | 2016 | 198 | 0.520 |
Why?
|
| Milk Proteins | 2 | 2011 | 95 | 0.510 |
Why?
|
| Dietary Sucrose | 2 | 2010 | 40 | 0.500 |
Why?
|
| Fatty Acids | 10 | 2020 | 377 | 0.500 |
Why?
|
| Male | 141 | 2024 | 64957 | 0.500 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 67 | 0.490 |
Why?
|
| Lipids | 4 | 2013 | 569 | 0.480 |
Why?
|
| Cross-Over Studies | 10 | 2020 | 258 | 0.470 |
Why?
|
| Adipose Tissue | 8 | 2023 | 502 | 0.470 |
Why?
|
| Fluid Therapy | 2 | 2015 | 141 | 0.460 |
Why?
|
| Brain Edema | 2 | 2015 | 66 | 0.460 |
Why?
|
| Ghrelin | 2 | 2012 | 58 | 0.440 |
Why?
|
| Child | 72 | 2024 | 26341 | 0.440 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2323 | 0.430 |
Why?
|
| Autoantibodies | 3 | 2013 | 451 | 0.430 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 112 | 0.420 |
Why?
|
| Liver | 23 | 2018 | 1796 | 0.410 |
Why?
|
| Injections, Subcutaneous | 12 | 2016 | 136 | 0.410 |
Why?
|
| Metformin | 6 | 2023 | 174 | 0.410 |
Why?
|
| Lipogenesis | 1 | 2014 | 61 | 0.400 |
Why?
|
| Breast | 2 | 2007 | 215 | 0.400 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 133 | 0.390 |
Why?
|
| Postprandial Period | 3 | 2009 | 93 | 0.390 |
Why?
|
| Early Medical Intervention | 1 | 2013 | 32 | 0.380 |
Why?
|
| Glutamate Decarboxylase | 1 | 2013 | 45 | 0.380 |
Why?
|
| Child Welfare | 1 | 2013 | 71 | 0.370 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.370 |
Why?
|
| Early Diagnosis | 1 | 2013 | 195 | 0.370 |
Why?
|
| Growth Disorders | 2 | 2013 | 181 | 0.350 |
Why?
|
| Dogs | 30 | 1993 | 613 | 0.350 |
Why?
|
| Fibrinogen | 5 | 1993 | 170 | 0.350 |
Why?
|
| Body Mass Index | 8 | 2018 | 1717 | 0.350 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 645 | 0.350 |
Why?
|
| Tritium | 14 | 1995 | 108 | 0.340 |
Why?
|
| Protein Biosynthesis | 11 | 2006 | 569 | 0.340 |
Why?
|
| Lactic Acid | 9 | 2015 | 149 | 0.340 |
Why?
|
| Recombinant Proteins | 13 | 2015 | 1319 | 0.340 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 192 | 0.340 |
Why?
|
| Metabolism | 3 | 2012 | 45 | 0.340 |
Why?
|
| Oligosaccharides | 2 | 2022 | 71 | 0.330 |
Why?
|
| Puberty | 7 | 2020 | 94 | 0.330 |
Why?
|
| Alanine | 22 | 2002 | 160 | 0.330 |
Why?
|
| Blood Chemical Analysis | 3 | 2021 | 79 | 0.310 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.310 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 9 | 2008 | 64 | 0.310 |
Why?
|
| Biomedical Research | 1 | 2015 | 561 | 0.300 |
Why?
|
| Diet | 7 | 2020 | 1121 | 0.300 |
Why?
|
| Gastric Emptying | 2 | 2008 | 79 | 0.290 |
Why?
|
| Epithelial Cells | 1 | 2013 | 905 | 0.290 |
Why?
|
| Glucocorticoids | 5 | 2009 | 348 | 0.290 |
Why?
|
| Deuterium | 14 | 2002 | 95 | 0.280 |
Why?
|
| Serum Albumin | 5 | 2003 | 101 | 0.280 |
Why?
|
| Caloric Restriction | 1 | 2009 | 107 | 0.270 |
Why?
|
| Lipolysis | 5 | 2020 | 83 | 0.270 |
Why?
|
| Hyperinsulinism | 6 | 2002 | 58 | 0.270 |
Why?
|
| Suction | 1 | 2007 | 48 | 0.270 |
Why?
|
| Blood Glucose Self-Monitoring | 5 | 2019 | 129 | 0.260 |
Why?
|
| Time Factors | 21 | 2013 | 6196 | 0.260 |
Why?
|
| Child, Preschool | 40 | 2017 | 15110 | 0.260 |
Why?
|
| Gene Expression | 2 | 2011 | 1481 | 0.250 |
Why?
|
| Body Composition | 7 | 2005 | 545 | 0.250 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 19 | 0.250 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 1801 | 0.250 |
Why?
|
| Diabetes Mellitus | 8 | 2013 | 889 | 0.240 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 141 | 0.240 |
Why?
|
| Food | 3 | 2003 | 121 | 0.240 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 46 | 0.240 |
Why?
|
| Weight Loss | 2 | 2009 | 538 | 0.240 |
Why?
|
| Isoleucine | 5 | 1991 | 24 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2016 | 1618 | 0.230 |
Why?
|
| Pediatric Obesity | 3 | 2024 | 419 | 0.230 |
Why?
|
| Hydrocortisone | 17 | 1993 | 215 | 0.230 |
Why?
|
| Microarray Analysis | 3 | 2012 | 222 | 0.230 |
Why?
|
| Glycogen | 3 | 2002 | 50 | 0.230 |
Why?
|
| Infusions, Intravenous | 11 | 2015 | 531 | 0.220 |
Why?
|
| Energy Intake | 7 | 2018 | 502 | 0.220 |
Why?
|
| Islet Amyloid Polypeptide | 4 | 2009 | 13 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 11 | 1993 | 318 | 0.210 |
Why?
|
| Lipid Droplets | 3 | 2011 | 51 | 0.210 |
Why?
|
| Reference Values | 15 | 2002 | 676 | 0.210 |
Why?
|
| Caprylates | 3 | 1991 | 19 | 0.200 |
Why?
|
| Animals | 43 | 2021 | 33912 | 0.200 |
Why?
|
| Epinephrine | 17 | 2003 | 150 | 0.200 |
Why?
|
| Hydroxybutyrates | 15 | 1992 | 31 | 0.200 |
Why?
|
| Calorimetry, Indirect | 5 | 2009 | 64 | 0.190 |
Why?
|
| Phenylbutyrates | 2 | 2006 | 54 | 0.190 |
Why?
|
| Lactates | 19 | 2009 | 82 | 0.190 |
Why?
|
| Parenteral Nutrition | 6 | 1996 | 219 | 0.190 |
Why?
|
| Infant | 24 | 2022 | 13352 | 0.180 |
Why?
|
| Reproducibility of Results | 6 | 2008 | 2904 | 0.180 |
Why?
|
| Receptors, Ghrelin | 2 | 2012 | 30 | 0.180 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2000 | 85 | 0.180 |
Why?
|
| Diabetic Nephropathies | 1 | 2023 | 115 | 0.180 |
Why?
|
| Glycomics | 1 | 2021 | 15 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 32 | 0.170 |
Why?
|
| Isotope Labeling | 6 | 2009 | 94 | 0.170 |
Why?
|
| Spleen | 1 | 2002 | 258 | 0.170 |
Why?
|
| Monitoring, Physiologic | 3 | 2013 | 376 | 0.170 |
Why?
|
| Kidney | 6 | 2015 | 1282 | 0.170 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 75 | 0.170 |
Why?
|
| Adolescent Development | 2 | 2013 | 29 | 0.170 |
Why?
|
| Glycogen Storage Disease Type I | 3 | 1986 | 10 | 0.170 |
Why?
|
| Acidosis | 4 | 1989 | 97 | 0.170 |
Why?
|
| 3-Hydroxybutyric Acid | 11 | 2002 | 22 | 0.170 |
Why?
|
| Carbon Dioxide | 6 | 2000 | 270 | 0.170 |
Why?
|
| Phenylalanine | 2 | 1993 | 130 | 0.170 |
Why?
|
| Receptor, Insulin | 3 | 2020 | 65 | 0.160 |
Why?
|
| Blood Proteins | 4 | 1999 | 143 | 0.160 |
Why?
|
| Adiposity | 2 | 2014 | 209 | 0.160 |
Why?
|
| Biochemistry | 1 | 2000 | 8 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2021 | 143 | 0.160 |
Why?
|
| Reye Syndrome | 7 | 1989 | 10 | 0.160 |
Why?
|
| Bodily Secretions | 1 | 2020 | 8 | 0.160 |
Why?
|
| Incretins | 1 | 2020 | 26 | 0.160 |
Why?
|
| Monosaccharides | 1 | 1999 | 21 | 0.150 |
Why?
|
| Alkenes | 1 | 1999 | 8 | 0.150 |
Why?
|
| Metagenome | 1 | 2020 | 138 | 0.150 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 3061 | 0.150 |
Why?
|
| Radioisotope Dilution Technique | 10 | 2000 | 37 | 0.150 |
Why?
|
| Amino Acids, Branched-Chain | 6 | 1991 | 75 | 0.150 |
Why?
|
| Administration, Oral | 4 | 2009 | 711 | 0.150 |
Why?
|
| Infant, Newborn | 16 | 2015 | 8635 | 0.150 |
Why?
|
| Caproates | 5 | 1992 | 7 | 0.150 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 1991 | 81 | 0.140 |
Why?
|
| Wasting Syndrome | 1 | 1999 | 22 | 0.140 |
Why?
|
| Sodium Bicarbonate | 4 | 1995 | 57 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1490 | 0.140 |
Why?
|
| Gastroenteritis | 1 | 2001 | 308 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2020 | 410 | 0.140 |
Why?
|
| Hyperandrogenism | 1 | 1998 | 19 | 0.140 |
Why?
|
| Random Allocation | 3 | 2016 | 409 | 0.140 |
Why?
|
| Health Resources | 1 | 2019 | 131 | 0.130 |
Why?
|
| Prolactin | 2 | 2008 | 142 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 3 | 2005 | 50 | 0.130 |
Why?
|
| Carbohydrates | 2 | 2014 | 34 | 0.130 |
Why?
|
| Biological Transport | 3 | 2021 | 329 | 0.130 |
Why?
|
| Infant, Premature | 4 | 2006 | 872 | 0.130 |
Why?
|
| Registries | 2 | 2023 | 1634 | 0.130 |
Why?
|
| Drug Therapy, Combination | 7 | 2019 | 1173 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2002 | 327 | 0.130 |
Why?
|
| Isothiocyanates | 1 | 2017 | 12 | 0.130 |
Why?
|
| Threonine | 2 | 1987 | 62 | 0.130 |
Why?
|
| Beverages | 2 | 2014 | 99 | 0.130 |
Why?
|
| Sodium Chloride | 2 | 2015 | 89 | 0.130 |
Why?
|
| Endocrine System Diseases | 3 | 2015 | 42 | 0.130 |
Why?
|
| Overweight | 3 | 2017 | 387 | 0.130 |
Why?
|
| Triacetin | 2 | 1993 | 2 | 0.120 |
Why?
|
| Nitrogen | 5 | 1999 | 120 | 0.120 |
Why?
|
| Carnitine | 4 | 1991 | 70 | 0.120 |
Why?
|
| Trypsin | 3 | 1994 | 68 | 0.120 |
Why?
|
| Consensus | 2 | 2016 | 512 | 0.120 |
Why?
|
| Endocrinology | 2 | 2015 | 124 | 0.120 |
Why?
|
| Dwarfism, Pituitary | 1 | 2016 | 6 | 0.120 |
Why?
|
| Ketosis | 3 | 1989 | 15 | 0.120 |
Why?
|
| Lipase | 3 | 1994 | 91 | 0.120 |
Why?
|
| Dietary Proteins | 2 | 2009 | 225 | 0.120 |
Why?
|
| Ovary | 1 | 1998 | 345 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2019 | 407 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 232 | 0.110 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.110 |
Why?
|
| Amylases | 2 | 1994 | 20 | 0.110 |
Why?
|
| Community Networks | 1 | 2015 | 30 | 0.110 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 40 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 43 | 0.110 |
Why?
|
| Candy | 1 | 2014 | 8 | 0.110 |
Why?
|
| Child Development | 2 | 2013 | 266 | 0.110 |
Why?
|
| Pancreas | 4 | 1994 | 217 | 0.110 |
Why?
|
| Turner Syndrome | 1 | 2015 | 44 | 0.110 |
Why?
|
| Young Adult | 5 | 2018 | 10103 | 0.110 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 2085 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 224 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2014 | 238 | 0.100 |
Why?
|
| Acetoacetates | 11 | 1990 | 14 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2021 | 414 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2015 | 798 | 0.100 |
Why?
|
| Cohort Studies | 6 | 2023 | 5063 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 115 | 0.100 |
Why?
|
| Thinness | 1 | 2014 | 71 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2013 | 928 | 0.100 |
Why?
|
| Ketoglutaric Acids | 1 | 1993 | 26 | 0.100 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2008 | 113 | 0.100 |
Why?
|
| Morbidity | 1 | 2014 | 256 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 187 | 0.100 |
Why?
|
| Pregnancy | 7 | 2014 | 7512 | 0.100 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2013 | 11 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2016 | 282 | 0.100 |
Why?
|
| Viscera | 1 | 1993 | 56 | 0.100 |
Why?
|
| Adrenocortical Hyperfunction | 2 | 1986 | 2 | 0.090 |
Why?
|
| Incidence | 2 | 2015 | 3360 | 0.090 |
Why?
|
| Body Height | 2 | 2013 | 192 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2013 | 96 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1993 | 437 | 0.090 |
Why?
|
| Nitrogen Isotopes | 4 | 2003 | 45 | 0.090 |
Why?
|
| Food Deprivation | 1 | 2012 | 33 | 0.090 |
Why?
|
| Hydrolysis | 3 | 2001 | 141 | 0.090 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 126 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 268 | 0.090 |
Why?
|
| Palmitic Acid | 2 | 2010 | 27 | 0.090 |
Why?
|
| Prednisolone | 1 | 1992 | 74 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 4 | 1986 | 740 | 0.090 |
Why?
|
| Fetal Diseases | 2 | 2015 | 440 | 0.090 |
Why?
|
| Infusions, Parenteral | 9 | 2007 | 79 | 0.090 |
Why?
|
| Glucose Clamp Technique | 5 | 2002 | 77 | 0.090 |
Why?
|
| Insulin Antagonists | 2 | 1991 | 4 | 0.090 |
Why?
|
| Mice | 6 | 2017 | 18301 | 0.090 |
Why?
|
| Brain Diseases | 5 | 1979 | 299 | 0.080 |
Why?
|
| Albumins | 1 | 1991 | 87 | 0.080 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 6 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 895 | 0.080 |
Why?
|
| Sex Factors | 3 | 2013 | 1356 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 1990 | 140 | 0.080 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2010 | 33 | 0.080 |
Why?
|
| Patient Safety | 1 | 2015 | 443 | 0.080 |
Why?
|
| Adaptation, Physiological | 2 | 2003 | 258 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 93 | 0.080 |
Why?
|
| Middle Aged | 19 | 2020 | 28601 | 0.080 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 47 | 0.080 |
Why?
|
| Isoflurane | 1 | 1990 | 35 | 0.080 |
Why?
|
| Body Weight | 6 | 2005 | 987 | 0.080 |
Why?
|
| Pyruvates | 8 | 1991 | 19 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 489 | 0.080 |
Why?
|
| Biomarkers | 2 | 2022 | 3385 | 0.080 |
Why?
|
| Drug Administration Schedule | 4 | 2007 | 732 | 0.080 |
Why?
|
| Health Behavior | 1 | 2013 | 387 | 0.080 |
Why?
|
| Osmolar Concentration | 4 | 1998 | 148 | 0.080 |
Why?
|
| Hexoses | 1 | 2009 | 10 | 0.080 |
Why?
|
| Age Factors | 4 | 2013 | 2825 | 0.080 |
Why?
|
| Insulinoma | 2 | 1986 | 8 | 0.080 |
Why?
|
| Chemoreceptor Cells | 1 | 2009 | 14 | 0.080 |
Why?
|
| Alkalosis | 1 | 1989 | 23 | 0.070 |
Why?
|
| Glycosuria | 2 | 2007 | 6 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 4738 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 6 | 1990 | 137 | 0.070 |
Why?
|
| Diet, Diabetic | 1 | 2009 | 6 | 0.070 |
Why?
|
| Sample Size | 1 | 2009 | 84 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2023 | 351 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2021 | 365 | 0.070 |
Why?
|
| Halothane | 1 | 1988 | 7 | 0.070 |
Why?
|
| Calcium | 5 | 2006 | 1010 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2015 | 722 | 0.070 |
Why?
|
| Adenoma, Islet Cell | 2 | 1986 | 5 | 0.070 |
Why?
|
| Health Expenditures | 1 | 2010 | 136 | 0.070 |
Why?
|
| Nitrous Oxide | 1 | 1988 | 12 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2009 | 304 | 0.070 |
Why?
|
| Peptide Hydrolases | 2 | 1993 | 131 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2009 | 92 | 0.070 |
Why?
|
| Texas | 2 | 2015 | 3686 | 0.070 |
Why?
|
| Maple Syrup Urine Disease | 3 | 1980 | 14 | 0.070 |
Why?
|
| Pancreatectomy | 4 | 1990 | 146 | 0.070 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.070 |
Why?
|
| Muscular Dystrophies | 2 | 1998 | 51 | 0.070 |
Why?
|
| Lactalbumin | 1 | 2007 | 12 | 0.070 |
Why?
|
| Somatostatin | 8 | 1993 | 60 | 0.070 |
Why?
|
| Gastrointestinal Motility | 1 | 2008 | 65 | 0.070 |
Why?
|
| Fatty Liver | 2 | 2009 | 224 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 87 | 0.070 |
Why?
|
| Breath Tests | 4 | 2000 | 182 | 0.070 |
Why?
|
| Lung Diseases | 1 | 1992 | 398 | 0.070 |
Why?
|
| Circadian Rhythm | 5 | 2004 | 327 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2019 | 12936 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2009 | 173 | 0.070 |
Why?
|
| Emetine | 1 | 1987 | 2 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 420 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 822 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3819 | 0.060 |
Why?
|
| Epithelium | 1 | 2007 | 335 | 0.060 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2002 | 63 | 0.060 |
Why?
|
| Hemangioendothelioma | 1 | 2007 | 24 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 1680 | 0.060 |
Why?
|
| Muscles | 4 | 1991 | 197 | 0.060 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 44 | 0.060 |
Why?
|
| Capillaries | 1 | 2006 | 63 | 0.060 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 53 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 710 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1986 | 22 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 60 | 0.060 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1986 | 14 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2007 | 71 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 373 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 889 | 0.060 |
Why?
|
| Injections, Intravenous | 5 | 1995 | 239 | 0.060 |
Why?
|
| Transcriptome | 1 | 2013 | 1103 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2013 | 3711 | 0.060 |
Why?
|
| Acanthosis Nigricans | 1 | 1986 | 11 | 0.060 |
Why?
|
| Pancreatic Cyst | 1 | 1986 | 28 | 0.060 |
Why?
|
| Urea | 2 | 2003 | 220 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2002 | 125 | 0.060 |
Why?
|
| Brain | 9 | 1991 | 3175 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3829 | 0.060 |
Why?
|
| Respiration | 3 | 2003 | 117 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 321 | 0.060 |
Why?
|
| Androgens | 3 | 1998 | 247 | 0.060 |
Why?
|
| Glycolysis | 2 | 2005 | 174 | 0.060 |
Why?
|
| Age of Onset | 2 | 2019 | 592 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 1205 | 0.060 |
Why?
|
| Anthropometry | 2 | 2018 | 187 | 0.060 |
Why?
|
| Organosilicon Compounds | 1 | 1984 | 2 | 0.050 |
Why?
|
| Silicon | 1 | 1984 | 13 | 0.050 |
Why?
|
| Pancreatitis | 1 | 1986 | 139 | 0.050 |
Why?
|
| Malignant Hyperthermia | 1 | 1984 | 18 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 60 | 0.050 |
Why?
|
| RNA | 1 | 2007 | 517 | 0.050 |
Why?
|
| Phenotype | 2 | 2013 | 4497 | 0.050 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2020 | 19 | 0.050 |
Why?
|
| Intubation, Gastrointestinal | 2 | 1995 | 52 | 0.050 |
Why?
|
| Biology | 1 | 2024 | 24 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2003 | 323 | 0.050 |
Why?
|
| Insulin Glargine | 2 | 2019 | 8 | 0.050 |
Why?
|
| Adipocytes | 1 | 2005 | 178 | 0.050 |
Why?
|
| Bone and Bones | 2 | 2006 | 308 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4886 | 0.050 |
Why?
|
| Software | 1 | 2008 | 733 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2465 | 0.050 |
Why?
|
| Albuminuria | 1 | 2023 | 107 | 0.050 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 1999 | 39 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1363 | 0.050 |
Why?
|
| Adenoma | 1 | 1984 | 144 | 0.050 |
Why?
|
| Glucosamine | 1 | 1982 | 11 | 0.050 |
Why?
|
| Risk Factors | 3 | 2023 | 11074 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2023 | 566 | 0.050 |
Why?
|
| Bicarbonates | 5 | 1996 | 98 | 0.040 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 26 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 1982 | 132 | 0.040 |
Why?
|
| Patient Compliance | 2 | 2019 | 463 | 0.040 |
Why?
|
| Life Style | 2 | 2016 | 456 | 0.040 |
Why?
|
| Norepinephrine | 8 | 1993 | 149 | 0.040 |
Why?
|
| Growth Substances | 1 | 2002 | 99 | 0.040 |
Why?
|
| Testosterone | 2 | 1994 | 531 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 25 | 0.040 |
Why?
|
| Growth | 1 | 2002 | 93 | 0.040 |
Why?
|
| Hospitalization | 1 | 2010 | 1950 | 0.040 |
Why?
|
| Oxygen | 1 | 2005 | 548 | 0.040 |
Why?
|
| Ultrasonography | 1 | 1986 | 943 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 6 | 2003 | 126 | 0.040 |
Why?
|
| Multiple Endocrine Neoplasia | 3 | 1986 | 24 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 127 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 71 | 0.040 |
Why?
|
| Research Design | 2 | 2016 | 716 | 0.040 |
Why?
|
| Enteral Nutrition | 3 | 1996 | 290 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1983 | 61 | 0.040 |
Why?
|
| Glucose Solution, Hypertonic | 2 | 1978 | 2 | 0.040 |
Why?
|
| Safety | 1 | 2002 | 215 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 133 | 0.040 |
Why?
|
| Splanchnic Circulation | 2 | 1995 | 49 | 0.040 |
Why?
|
| History, 18th Century | 2 | 2000 | 68 | 0.040 |
Why?
|
| Gangliosides | 1 | 2021 | 72 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2015 | 17753 | 0.040 |
Why?
|
| Prevalence | 2 | 2008 | 2701 | 0.040 |
Why?
|
| Water | 1 | 2002 | 186 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2021 | 102 | 0.040 |
Why?
|
| Peptide YY | 1 | 2020 | 20 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 5196 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2020 | 77 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2000 | 109 | 0.040 |
Why?
|
| Hirsutism | 1 | 1979 | 22 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2002 | 245 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 43 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1993 | 37 | 0.040 |
Why?
|
| Infusion Pumps | 2 | 1997 | 31 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1061 | 0.040 |
Why?
|
| Immunocompetence | 1 | 1999 | 31 | 0.040 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 1999 | 70 | 0.040 |
Why?
|
| Sex Chromosomes | 1 | 1978 | 29 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 298 | 0.040 |
Why?
|
| Drug Costs | 1 | 2019 | 66 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 604 | 0.040 |
Why?
|
| Phosphates | 2 | 1978 | 112 | 0.040 |
Why?
|
| Hypoparathyroidism | 1 | 1978 | 10 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 151 | 0.040 |
Why?
|
| Consciousness | 2 | 1989 | 56 | 0.040 |
Why?
|
| Ethinyl Estradiol-Norgestrel Combination | 1 | 1998 | 2 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3359 | 0.030 |
Why?
|
| Basal Metabolism | 4 | 1996 | 93 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1999 | 172 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1984 | 614 | 0.030 |
Why?
|
| Clitoris | 1 | 1977 | 4 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 143 | 0.030 |
Why?
|
| Vulva | 1 | 1977 | 12 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 1977 | 19 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 21 | 0.030 |
Why?
|
| X Chromosome | 1 | 1978 | 327 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1978 | 220 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1147 | 0.030 |
Why?
|
| Disorders of Sex Development | 2 | 1980 | 69 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2017 | 15 | 0.030 |
Why?
|
| Calorimetry | 2 | 2003 | 63 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 31 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 1445 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1997 | 33 | 0.030 |
Why?
|
| Self Care | 1 | 2019 | 231 | 0.030 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2017 | 5 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1997 | 40 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 1991 | 30 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 197 | 0.030 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2017 | 25 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2200 | 0.030 |
Why?
|
| Drug Interactions | 4 | 1993 | 237 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 265 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 1833 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2023 | 1559 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 1976 | 19 | 0.030 |
Why?
|
| Birth Weight | 3 | 1974 | 347 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2009 | 194 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 1373 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 123 | 0.030 |
Why?
|
| Thiazoles | 1 | 2016 | 113 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 137 | 0.030 |
Why?
|
| Protein Deficiency | 1 | 1996 | 19 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1978 | 573 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1996 | 22 | 0.030 |
Why?
|
| Epilepsy | 1 | 1983 | 876 | 0.030 |
Why?
|
| Phentolamine | 6 | 1980 | 15 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 270 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 294 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1996 | 82 | 0.030 |
Why?
|
| Pediatrics | 2 | 2015 | 1252 | 0.030 |
Why?
|
| Microbiota | 1 | 2020 | 438 | 0.030 |
Why?
|
| Propranolol | 6 | 1980 | 110 | 0.030 |
Why?
|
| Nutritional Support | 1 | 1996 | 67 | 0.030 |
Why?
|
| Education | 1 | 2015 | 112 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 50 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 365 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1995 | 315 | 0.030 |
Why?
|
| Jejunostomy | 1 | 1994 | 21 | 0.030 |
Why?
|
| Octreotide | 1 | 1994 | 23 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 1129 | 0.030 |
Why?
|
| Sincalide | 1 | 1994 | 4 | 0.030 |
Why?
|
| Dexamethasone | 3 | 2009 | 250 | 0.030 |
Why?
|
| Adipates | 1 | 1993 | 1 | 0.030 |
Why?
|
| Catecholamines | 2 | 1991 | 49 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 45 | 0.030 |
Why?
|
| Isotopes | 1 | 1993 | 24 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 119 | 0.020 |
Why?
|
| Proinsulin | 1 | 1993 | 13 | 0.020 |
Why?
|
| Erythrocytes | 3 | 1989 | 186 | 0.020 |
Why?
|
| Parents | 1 | 2001 | 1128 | 0.020 |
Why?
|
| United States | 2 | 2013 | 12072 | 0.020 |
Why?
|
| Heart Defects, Congenital | 2 | 1989 | 1889 | 0.020 |
Why?
|
| Arginine | 6 | 1990 | 340 | 0.020 |
Why?
|
| Caregivers | 1 | 2019 | 598 | 0.020 |
Why?
|
| Organ Size | 2 | 1984 | 407 | 0.020 |
Why?
|
| Diet Therapy | 1 | 1973 | 40 | 0.020 |
Why?
|
| Mathematics | 2 | 1990 | 71 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2015 | 210 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2552 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1996 | 334 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 74 | 0.020 |
Why?
|
| Heart Rate | 4 | 2009 | 577 | 0.020 |
Why?
|
| Duodenum | 1 | 1992 | 111 | 0.020 |
Why?
|
| Coma | 1 | 1991 | 56 | 0.020 |
Why?
|
| Physical Exertion | 2 | 1990 | 63 | 0.020 |
Why?
|
| Sodium | 2 | 1990 | 280 | 0.020 |
Why?
|
| Cortisone | 3 | 1983 | 11 | 0.020 |
Why?
|
| Fruit | 1 | 2013 | 227 | 0.020 |
Why?
|
| Mutation | 1 | 2005 | 6099 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 726 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 338 | 0.020 |
Why?
|
| Radiography | 2 | 2006 | 743 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 61 | 0.020 |
Why?
|
| Vegetables | 1 | 2013 | 267 | 0.020 |
Why?
|
| Biological Availability | 1 | 1991 | 136 | 0.020 |
Why?
|
| Home Care Services | 2 | 1989 | 73 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 1991 | 170 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 1992 | 333 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1990 | 60 | 0.020 |
Why?
|
| Health Services | 1 | 2010 | 69 | 0.020 |
Why?
|
| Methylhistidines | 1 | 1989 | 7 | 0.020 |
Why?
|
| Pancreatic Hormones | 1 | 1989 | 5 | 0.020 |
Why?
|
| Body Temperature | 1 | 1990 | 126 | 0.020 |
Why?
|
| Thyrotropin | 2 | 2007 | 50 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1989 | 40 | 0.020 |
Why?
|
| Triiodothyronine | 2 | 2007 | 50 | 0.020 |
Why?
|
| Thyroxine | 2 | 2007 | 53 | 0.020 |
Why?
|
| Scintillation Counting | 1 | 1989 | 7 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 1989 | 13 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1989 | 17 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1994 | 82 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 326 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 26 | 0.020 |
Why?
|
| Estrogens | 2 | 1996 | 434 | 0.020 |
Why?
|
| Heparin | 3 | 1986 | 208 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 767 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 61 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1989 | 86 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1973 | 420 | 0.020 |
Why?
|
| Salicylates | 1 | 1989 | 54 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1626 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1989 | 358 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 58 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 761 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2009 | 91 | 0.020 |
Why?
|
| Pregnancy Complications | 2 | 1973 | 567 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 276 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 1988 | 12 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 260 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 187 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 1988 | 6 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 1339 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1797 | 0.020 |
Why?
|
| Insulin Antibodies | 2 | 1984 | 7 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 1988 | 97 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 306 | 0.020 |
Why?
|
| Luteinizing Hormone | 2 | 1996 | 118 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 889 | 0.020 |
Why?
|
| Insulin, Long-Acting | 2 | 2004 | 5 | 0.020 |
Why?
|
| Ethanol | 1 | 1989 | 170 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 1989 | 362 | 0.020 |
Why?
|
| Lipid Mobilization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Forearm | 1 | 1987 | 39 | 0.020 |
Why?
|
| Exercise | 1 | 1993 | 892 | 0.020 |
Why?
|
| Demography | 1 | 1987 | 237 | 0.020 |
Why?
|
| Glycine | 2 | 1996 | 156 | 0.020 |
Why?
|
| Feminization | 1 | 1986 | 2 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 1991 | 514 | 0.020 |
Why?
|
| Absorption | 1 | 1986 | 49 | 0.020 |
Why?
|
| Hindlimb | 2 | 1990 | 72 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 93 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 63 | 0.020 |
Why?
|
| Herpes Simplex | 2 | 1981 | 59 | 0.020 |
Why?
|
| Hyperaldosteronism | 1 | 1986 | 17 | 0.020 |
Why?
|
| Sympathetic Nervous System | 2 | 1976 | 51 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1986 | 22 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1986 | 30 | 0.010 |
Why?
|
| Acromegaly | 1 | 1986 | 9 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 56 | 0.010 |
Why?
|
| Magnesium | 1 | 2006 | 114 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 1986 | 23 | 0.010 |
Why?
|
| Niacin | 1 | 1986 | 59 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1986 | 86 | 0.010 |
Why?
|
| Phosphorus | 2 | 1975 | 60 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1986 | 123 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1985 | 24 | 0.010 |
Why?
|
| Insulin Lispro | 1 | 2004 | 2 | 0.010 |
Why?
|
| Insulin Aspart | 1 | 2004 | 2 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1984 | 13 | 0.010 |
Why?
|
| Glucosephosphates | 1 | 1984 | 2 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 1984 | 3 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 1984 | 18 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 3763 | 0.010 |
Why?
|
| Propionates | 1 | 1984 | 31 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2304 | 0.010 |
Why?
|
| Palmitates | 3 | 1989 | 17 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 109 | 0.010 |
Why?
|
| Granulocytes | 1 | 1984 | 69 | 0.010 |
Why?
|
| Dehydration | 1 | 1983 | 40 | 0.010 |
Why?
|
| Electrolytes | 1 | 1983 | 59 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 991 | 0.010 |
Why?
|
| Microchemistry | 1 | 1983 | 3 | 0.010 |
Why?
|
| Virus Diseases | 2 | 1976 | 285 | 0.010 |
Why?
|
| Chemistry | 1 | 1982 | 24 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 46 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1983 | 79 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 4066 | 0.010 |
Why?
|
| Pancreatic Polypeptide | 1 | 1982 | 5 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2003 | 93 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1272 | 0.010 |
Why?
|
| Theophylline | 1 | 1982 | 23 | 0.010 |
Why?
|
| Recurrence | 1 | 1986 | 1489 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1982 | 7 | 0.010 |
Why?
|
| Pedigree | 1 | 1986 | 1677 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 1982 | 19 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1982 | 140 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 37 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1980 | 6 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1983 | 1216 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1980 | 15 | 0.010 |
Why?
|
| Carbon | 1 | 1980 | 101 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1980 | 42 | 0.010 |
Why?
|
| Norethynodrel | 1 | 1979 | 1 | 0.010 |
Why?
|
| Mestranol | 1 | 1979 | 2 | 0.010 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 1979 | 7 | 0.010 |
Why?
|
| Chimera | 1 | 1980 | 79 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1979 | 44 | 0.010 |
Why?
|
| Bone Development | 2 | 1996 | 58 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1979 | 175 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1980 | 216 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1826 | 0.010 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1979 | 67 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1982 | 401 | 0.010 |
Why?
|
| Rickets | 1 | 1978 | 10 | 0.010 |
Why?
|
| Mitochondria | 2 | 1991 | 785 | 0.010 |
Why?
|
| Citric Acid Cycle | 2 | 1977 | 43 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1978 | 83 | 0.010 |
Why?
|
| Indicator Dilution Techniques | 1 | 1998 | 24 | 0.010 |
Why?
|
| Pyruvate Carboxylase Deficiency Disease | 1 | 1977 | 1 | 0.010 |
Why?
|
| Blood | 2 | 1976 | 98 | 0.010 |
Why?
|
| In Vitro Techniques | 4 | 1984 | 808 | 0.010 |
Why?
|
| Vulvar Diseases | 1 | 1977 | 13 | 0.010 |
Why?
|
| Protein Binding | 1 | 1982 | 1652 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1978 | 134 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1977 | 48 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1976 | 3 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1996 | 31 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1976 | 18 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1976 | 37 | 0.010 |
Why?
|
| Hormones, Ectopic | 1 | 1976 | 7 | 0.010 |
Why?
|
| Acetates | 2 | 1991 | 77 | 0.010 |
Why?
|
| Fibroblasts | 3 | 1991 | 849 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1976 | 74 | 0.010 |
Why?
|
| Vasopressins | 1 | 1976 | 42 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 1996 | 45 | 0.010 |
Why?
|
| Mannitol | 1 | 1975 | 40 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1973 | 85 | 0.010 |
Why?
|
| Acid-Base Imbalance | 1 | 1975 | 25 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1996 | 69 | 0.010 |
Why?
|
| Levodopa | 1 | 1975 | 92 | 0.010 |
Why?
|
| Encephalomalacia | 1 | 1975 | 4 | 0.010 |
Why?
|
| Streptozocin | 1 | 1975 | 25 | 0.010 |
Why?
|
| Hyponatremia | 1 | 1976 | 73 | 0.010 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1976 | 77 | 0.010 |
Why?
|
| Parenteral Nutrition, Home | 1 | 1994 | 8 | 0.010 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 20 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1994 | 123 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1994 | 73 | 0.010 |
Why?
|
| Brain Stem | 1 | 1975 | 108 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1974 | 56 | 0.010 |
Why?
|
| Veins | 1 | 1974 | 95 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1975 | 212 | 0.010 |
Why?
|
| Short Bowel Syndrome | 1 | 1994 | 61 | 0.010 |
Why?
|
| Glutamate Dehydrogenase | 1 | 1973 | 3 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 29 | 0.010 |
Why?
|
| Pregnanetriol | 1 | 1973 | 1 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1973 | 1 | 0.010 |
Why?
|
| Virilism | 1 | 1973 | 13 | 0.010 |
Why?
|
| Monocytes | 2 | 1986 | 335 | 0.010 |
Why?
|
| Glutamates | 1 | 1973 | 53 | 0.010 |
Why?
|
| Gestational Age | 2 | 1974 | 1224 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1973 | 9 | 0.010 |
Why?
|
| Acute Disease | 1 | 1976 | 1153 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1978 | 963 | 0.010 |
Why?
|
| Karyotyping | 1 | 1973 | 308 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1976 | 810 | 0.010 |
Why?
|
| Alloxan | 2 | 1982 | 2 | 0.010 |
Why?
|
| Dwarfism | 1 | 1973 | 101 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1991 | 5 | 0.010 |
Why?
|
| Idoxuridine | 1 | 1971 | 5 | 0.010 |
Why?
|
| Portal System | 1 | 1991 | 34 | 0.010 |
Why?
|
| Floxuridine | 1 | 1971 | 7 | 0.010 |
Why?
|
| Pulse | 2 | 1985 | 28 | 0.010 |
Why?
|
| Portal Vein | 2 | 1982 | 84 | 0.010 |
Why?
|
| Smoking | 1 | 1976 | 932 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1991 | 193 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1990 | 9 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1973 | 177 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1973 | 255 | 0.010 |
Why?
|
| Liver Circulation | 1 | 1990 | 18 | 0.000 |
Why?
|
| Leukocytes | 1 | 1991 | 205 | 0.000 |
Why?
|
| Encephalitis | 1 | 1971 | 122 | 0.000 |
Why?
|
| Blood Pressure | 3 | 1984 | 1345 | 0.000 |
Why?
|
| Tyrosine | 1 | 1970 | 142 | 0.000 |
Why?
|
| Perfusion | 3 | 1975 | 209 | 0.000 |
Why?
|
| Periodicity | 1 | 1969 | 48 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 771 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1971 | 223 | 0.000 |
Why?
|
| Biopsy, Needle | 1 | 1988 | 204 | 0.000 |
Why?
|
| Aged | 4 | 1994 | 21025 | 0.000 |
Why?
|
| Pneumococcal Infections | 1 | 1969 | 281 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1991 | 2885 | 0.000 |
Why?
|
| Rats | 3 | 1975 | 3370 | 0.000 |
Why?
|
| Syndrome | 2 | 1979 | 1155 | 0.000 |
Why?
|
| Binding Sites | 1 | 1986 | 1133 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1982 | 65 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1982 | 91 | 0.000 |
Why?
|
| Autopsy | 1 | 1981 | 111 | 0.000 |
Why?
|
| Kidd Blood-Group System | 1 | 1980 | 1 | 0.000 |
Why?
|
| Inulin | 1 | 1980 | 16 | 0.000 |
Why?
|
| Decarboxylation | 1 | 1979 | 2 | 0.000 |
Why?
|
| Dichloroacetic Acid | 1 | 1979 | 13 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1980 | 61 | 0.000 |
Why?
|
| Fertilization | 1 | 1980 | 44 | 0.000 |
Why?
|
| Meiosis | 1 | 1980 | 111 | 0.000 |
Why?
|
| Necrosis | 1 | 1979 | 192 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1980 | 177 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1979 | 576 | 0.000 |
Why?
|
| Coenzyme A | 1 | 1977 | 6 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1977 | 20 | 0.000 |
Why?
|
| Citrates | 1 | 1977 | 24 | 0.000 |
Why?
|
| Vasoconstriction | 1 | 1978 | 94 | 0.000 |
Why?
|
| Posture | 1 | 1978 | 138 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1979 | 1571 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1977 | 357 | 0.000 |
Why?
|
| Complement Fixation Tests | 1 | 1975 | 29 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1977 | 269 | 0.000 |
Why?
|
| Glyceraldehyde | 1 | 1975 | 28 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1975 | 12 | 0.000 |
Why?
|
| Missouri | 1 | 1975 | 42 | 0.000 |
Why?
|
| Chickenpox | 1 | 1975 | 22 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1975 | 27 | 0.000 |
Why?
|
| Spermine Synthase | 1 | 1975 | 2 | 0.000 |
Why?
|
| Paramyxoviridae Infections | 1 | 1975 | 49 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1975 | 106 | 0.000 |
Why?
|
| Adenoviridae Infections | 1 | 1975 | 75 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1975 | 237 | 0.000 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1975 | 156 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1975 | 106 | 0.000 |
Why?
|
| Synapses | 1 | 1978 | 425 | 0.000 |
Why?
|
| Viruses | 1 | 1975 | 117 | 0.000 |
Why?
|
| Genes, Dominant | 1 | 1975 | 242 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1975 | 552 | 0.000 |
Why?
|
| Glycogen Synthase | 1 | 1973 | 8 | 0.000 |
Why?
|
| Diazoxide | 1 | 1973 | 8 | 0.000 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1973 | 17 | 0.000 |
Why?
|
| Glycoside Hydrolases | 1 | 1973 | 16 | 0.000 |
Why?
|
| Galactosemias | 1 | 1973 | 13 | 0.000 |
Why?
|
| Adrenal Gland Diseases | 1 | 1973 | 11 | 0.000 |
Why?
|
| Liver Glycogen | 1 | 1973 | 20 | 0.000 |
Why?
|
| Glucosyltransferases | 1 | 1973 | 44 | 0.000 |
Why?
|
| Infant Food | 1 | 1973 | 74 | 0.000 |
Why?
|
| Pancreatic Diseases | 1 | 1973 | 41 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1973 | 191 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1975 | 573 | 0.000 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1971 | 9 | 0.000 |
Why?
|
| Urine | 1 | 1971 | 89 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1971 | 305 | 0.000 |
Why?
|
| Cerebrospinal Fluid | 1 | 1971 | 99 | 0.000 |
Why?
|
| Saliva | 1 | 1971 | 125 | 0.000 |
Why?
|
| Pneumonia, Viral | 1 | 1975 | 351 | 0.000 |
Why?
|
| Cytomegalovirus | 1 | 1971 | 259 | 0.000 |
Why?
|
| Virulence | 1 | 1969 | 268 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1969 | 242 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1975 | 712 | 0.000 |
Why?
|